Conversely, chronic low-level IFN exposure can induce pro-tumor effects by fostering immunosuppression and resistance to RT and chemotherapy [82], and endogenous IFN/STAT1 activation has been associated with poor prognosis in proneural GBM [63]. This evidence concerns the gene IFNA1 and glioblastoma.